1263860

Athena Bioscience, LLC — FEI 3014412596

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Watkinsville, GA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)